← Back to Clinical Trials
Recruiting NCT06903364

NCT06903364 Association of Lifestyle With Complications in the Diabetic Population

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06903364
Status Recruiting
Phase
Sponsor Nanfang Hospital, Southern Medical University
Condition Diabetes Mellitus
Study Type OBSERVATIONAL
Enrollment 800 participants
Start Date 2024-08-01
Primary Completion 2028-03-30

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 800 participants in total. It began in 2024-08-01 with a primary completion date of 2028-03-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is a prospective study of patients with diabetes. The main objective of this study is to investigate the relationship between lifestyle and long-term complications in diabetic patients, which will help to screen out the high-risk group at an early stage and provide scientific advice for the prevention of complications in diabetic patients.

Eligibility Criteria

Inclusion Criteria: 1. Patients with a normative diagnosis of type 2 diabetes 2. Age ≥20 years old, regardless of gender 3. From January 2022 to December 2025, he was treated in Nanfang Hospital Exclusion Criteria: 1. In the acute infection phase 2. The researchers judged that it was not suitable to participate in this study

Contact & Investigator

Central Contact

Meng-Chen Zou

✉ zoumc@smu.edu.cn

📞 +86186 8842 3756

Frequently Asked Questions

Who can join the NCT06903364 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, studying Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06903364 currently recruiting?

Yes, NCT06903364 is actively recruiting participants. Contact the research team at zoumc@smu.edu.cn for enrollment information.

Where is the NCT06903364 trial being conducted?

This trial is being conducted at Guangzhou, China.

Who is sponsoring the NCT06903364 clinical trial?

NCT06903364 is sponsored by Nanfang Hospital, Southern Medical University. The trial plans to enroll 800 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology